Cellectar Biosciences's total assets for Q2 2025 were $13.70M, a decrease of -14.63% from the previous quarter. CLRB total liabilities were $6.23M for the fiscal quarter, a -20.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.